Announced details
Academic drug discovery research, medical literature searches, searches for associations between genes and diseases, and hypothesis generation by researchers
Licensing arrangement for KIBIT Amanogawa (recipients will be determined through an application and screening process)
Students, staff and researchers affiliated with universities, graduate schools and research institutions in Japan
Free of charge (use licenses provided)
The company does not address Contract Value / Impact on Business Performance.
PubMed (the biomedical and life sciences literature database of the U.S. National Library of Medicine and the National Center for Biotechnology Information)
| Item | Details |
|---|---|
| Names of Products / Services Covered | KIBIT Amanogawa, KIBIT Amanogawa for Academia Program |
| Counterparty | Universities, graduate schools and research institutions (individual recipients have not yet been selected) |
| Counterparty overview | Students, staff and researchers affiliated with universities, graduate schools and research institutions in Japan |
| Relationship with the Company | Licensing arrangement for KIBIT Amanogawa (recipients will be determined through an application and screening process) |
| Offering price | Free of charge (use licenses provided) |
| Launch date | November 2026 (scheduled) through the end of December 2027 |
| Applicable area | Academic drug discovery research, medical literature searches, searches for associations between genes and diseases, and hypothesis generation by researchers |
| Source | PubMed (the biomedical and life sciences literature database of the U.S. National Library of Medicine and the National Center for Biotechnology Information) |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To support new ideas and hypothesis generation by researchers in basic research settings at universities and research institutions, and contribute to the creation of innovative pharmaceuticals originating in Japan.